Previous studies found that total SOD activity was significantly increased in lung tumor tissues [9], while in the study performed by Ho et al. [27], total SOD activity in erythrocytes was decreased in lung cancer patients compared to the control group, and significantly lower activity was also associated with the presence of clinically evident metastatic (stage IV) disease [27]. The gene discussed is SOD1; the disease is lung carcinoma.